Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Tanya Dougherty, PharmD, BCPS

Articles by Tanya Dougherty, PharmD, BCPS

Type 2 Diabetes in the US Managed Care Setting: The Burden of Disease and Rationale for an Oral Glucagon-like Peptide-1 Receptor Agonist

ByTanya Dougherty, PharmD, BCPS,Michael Heile, MD, FAAFP

December 14th 2020

Efficacy of Oral Semaglutide: Overview of the PIONEER Clinical Trial Program and Implications for Managed Care

ByHelena W. Rodbard, MD, FACP, MACE,Tanya Dougherty, PharmD, BCPS,Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP

December 13th 2020

Cardiovascular Outcomes, Safety, and Tolerability With Oral Semaglutide: Insights for Managed Care

ByIldiko Lingvay, MD, MPH, MSCS,Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP,Tanya Dougherty, PharmD, BCPS

December 12th 2020

The Importance of Patient-Reported Outcomes in Type 2 Diabetes: Insight From the PIONEER Program With Oral Semaglutide

ByDoron Schneider, MD,Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP,Tanya Dougherty, PharmD, BCPS

December 11th 2020

Latest Updated Articles

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Nutrition in Pregnancy May Shape Metabolic Health After Delivery

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes